ArticleDrug design, development and therapy2023

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects.

Junlong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.